US FDA Issues Final Guidance for Certain Labeling Recommendations for Breast Implants


Your substances

None


Today, the U.S. Food and Drug Administration issued the final guidance, “Breast Implants - Certain Labeling Recommendations to Improve Patient Communication,” as part of the agency’s effort to help improve the information available to patients and health care professionals about the risks of breast implants. The draft guidance of this document was issued in 2019.

CONTINUE READING ON www.fda.gov

                   

Related News

Loading...